Picture of Avanos Medical logo

AVNS Avanos Medical Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Annual cashflow statement for Avanos Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-45.9-27.25.250.5-61.8
Depreciation
Deferred Taxes
Non-Cash Items11.135.821.21788.5
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital-59.6-67.826-24.3-18
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-74.5-2.587.390.932.4
Capital Expenditures-50.6-20.2-21-19.3-17.8
Purchase of Fixed Assets
Other Investing Cash Flow Items-57.5-40-11639.4
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Cash from Investing Activities-108-24.2-21-13521.6
Financing Cash Flow Items0-2.70-2.9-11.7
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.5-70-55.356.7-94.2
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-179-93.879.2-40